May 4, 2026

Amgen dismisses bone density concerns related to its weight-loss drug

Team metabolic Health Amgen (AMGN.O), has said that there was no link between its experimental weight-loss drug and changes in bone density, a day after those concerns wiped off more than $12 billion from the company’s market value. The drugmaker’s stock slumped 7% on Tuesday after analysts at Cantor Fitzgerald said their review of early-stage data […]

Community-led intervention curbs childhood obesity and boosts quality of life

Team Metabolic Health A new study finds that empowering communities with systems-based tools to fight childhood obesity not only reduced weight trends but also improved quality of life in boys—suggesting a resilient, community-first approach to lasting health changes. The RESPOND randomized trial is a community-based systems intervention to prevent childhood obesity and non-communicable diseases. Scientists […]

Weight loss injections and cancer: 6 questions, answered

Team Metabolic Health Most people know that losing weight has numerous benefits, but making major lifestyle changes can be extremely difficult. For example, obese people are often at risk for injuries when they start a new exercise routine, which can set them back or ultimately cause them to give up on it. As a result, more and more people have been […]

Limiting fast-food outlets can reduce childhood overweight and obesity

Team Metabolic Health Restricting new fast-food sellers in areas where there are already a large number could reduce obesity and overweight in children. In a recent study published in obesity, researchers investigated whether a policy in England that banned new fast-food outlets effectively reduced obesity and overweight in children. Their findings indicated that restricting new fast-food […]

Can a popular weight-loss drug reduce risk of Alzheimer’s?

Team Metabolic Health Alzheimer’s causes a gradual decline in memory, thinking, behaviour, and social skills, and it is the most common cause of dementia. According to the new study published in the journal Alzheimer’s & Dementia on Thursday, semaglutide was found to significantly lower the risk of developing AD compared to other diabetes medicines. Specifically, […]

How ‘miracle’ weight-loss drugs will change the world

Team Metabolic Health Models suggest societal upheaval from anti-obesity medicines — but impacts are hard to predict. Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left more money in people’s wallets. Lighter passengers are saving airlines 100 million litres of fuel each […]

Tirzepatide safe, effective for weight loss, preventing diabetes progression at 3 years

Team Metabolic Health Tirzepatide demonstrated long-term weight-loss benefits and prevention of diabetes progression in patients with obesity and prediabetes, but only so long as they continued the weight-loss medication, a speaker reported. The SURMOUNT-1 trial was a randomized, double-blind, placebo-controlled study for which patients with overweight plus one weight-related comorbidity or obesity and without diabetes […]

Zealand Pharma to start Phase 2b trial for obesity drug candidate in Q4

Team Metabolic Health Danish biotechnology company Zealand Pharma (ZELA.CO), said on Thursday it expected to initiate a so-called Phase 2b trial with its obesity treatment candidate petrelintide in the fourth quarter of 2024. “We look forward to initiating a large, comprehensive Phase 2b trial very soon and are now exploring collaboration opportunities with potential partners,” […]

80% of Strokes Are Preventable and GLP-1 drugs are beneficial for cardiovascular health

Finding to be extremely effective in treating risk factors for stroke, American Stroke Association incorporates the important new class of drug GLP-1 agonists. Team Metabolic Health The American Stroke Association has updated its guidelines on stroke risk reduction for the first time since 2014. In their recommendations, the ASA urges healthcare professionals to carefully screen […]

Can weight loss drug semaglutide slow down ageing? Here’s looking at its multiple benefits

Team Metabolic Health Given their effects on various organs, they could potentially help you remain functional “New diabetes drugs may delay ageing” made headlines across the media. The reference was to a study using glucagon-like peptide receptor agonist (GLP1RA), which mimics the hormone incretin to regulate appetite and blood glucose levels. Semaglutide, popularly known as […]